AxoGen (AXGN) Misses Q1 EPS by 4c

AxoGen (NASDAQ: AXGN) reported Q1 EPS of ($0.02), $0.04 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $48.56 million versus the consensus estimate of $48.66 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Blue Owl Credit Income Corp caps Q2 tender offer at 5% of shares
• Ford reports Q2 sales dip as SUVs and F-Series drive retail share
• Tesla Q2 deliveries reach 480,126, topping estimates of 406,024